JP Morgan Chase’s AdvisorShares Alpha DNA Equity Sentiment ETF SENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,869
Closed -$149K 7186
2022
Q3
$149K Buy
6,869
+5,929
+631% +$130K ﹤0.01% 5091
2022
Q2
$19K Buy
+940
New +$21K ﹤0.01% 5910

Other funds holding SENT

JP Morgan Chase's SENT Position: Q4 2022 in Review

JP Morgan Chase sold out of AdvisorShares Alpha DNA Equity Sentiment ETF (SENT) in Q4 2022, closing a stake of 6,869 shares — an estimated $149K sold.

JP Morgan Chase first reported a position in SENT in Q2 2022 and held it in 2 quarters. The position peaked at $149K in Q3 2022. 13 funds tracked by Wall St. Rank hold SENT as of Q4 2022.

  • JP Morgan Chase reported no remaining AdvisorShares Alpha DNA Equity Sentiment ETF position as of Q4 2022 after selling out during the quarter.
  • JP Morgan Chase sold 6,869 AdvisorShares Alpha DNA Equity Sentiment ETF shares in Q4 2022, an estimated $149K.
  • JP Morgan Chase first reported a position in AdvisorShares Alpha DNA Equity Sentiment ETF in Q2 2022 and held it in 2 quarters.
  • JP Morgan Chase's AdvisorShares Alpha DNA Equity Sentiment ETF position peaked at $149K in Q3 2022.
  • 13 funds tracked by Wall St. Rank held AdvisorShares Alpha DNA Equity Sentiment ETF as of Q4 2022.

Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.